IL-13 is a driver of COVID-19 severity

Mostrar otras versiones (1)

Immune dysregulation is characteristic of the more severe stages of SARS-CoV-2 infection. Understanding the mechanisms by which the immune system contributes to COVID-19 severity may open new avenues to treatment. Here, we report that elevated IL-13 was associated with the need for mechanical ventil...

Descripción completa

Detalles Bibliográficos
Autores principales: Donlan, Alexandra N., Sutherland, Tara E., Marie, Chelsea, Preissner, Saskia, Bradley, Benjamin T., Carpenter, Rebecca M., Sturek, Jeffrey M., Ma, Jennie Z., Moreau, G. Brett, Donowitz, Jeffrey R., Buck, Gregory A., Serrano, Myrna G., Burgess, Stacey L., Abhyankar, Mayuresh M., Mura, Cameron, Bourne, Philip E., Preissner, Robert, Young, Mary K., Lyons, Genevieve R., Loomba, Johanna J., Ratcliffe, Sarah J., Poulter, Melinda D., Mathers, Amy J., Day, Anthony J., Mann, Barbara J., Allen, Judith E., Petri, William A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410056/
https://www.ncbi.nlm.nih.gov/pubmed/34185704
http://dx.doi.org/10.1172/jci.insight.150107
Mostrar todas las versiones(2)

Ejemplares similares